Ranbaxy Laboratories and Daiichi Sankyo announced that the portfolio of the Daiichi Sankyo would be commercialized in Mexico through a recently created marketing division within Ranbaxy Mexico S.A. De C.V, a subsidiary of Ranbaxy.
This hybrid model will enable the companies to leverage their respective strengths in dominant prescription segment, through the newly created division, while continuing expansion in the rapidly evolving Generics market.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.